What's in Stiftung Institut fuer Herzinfarktforschung's pipeline?

Stiftung Institut fuer Herzinfarktforschung has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Stiftung Institut fuer Herzinfarktforschung's portfolio?

Top competitors by shared drug class: Azienda Policlinico Umberto I, Hospital Central San Luis Potosi, Mexico, Sanofi, Seung-Jung Park, US Department of Veterans Affairs.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/stiftung-institut-fuer-herzinfarktforschung.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Stiftung Institut fuer Herzinfarktforschung — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stiftung Institut fuer Herzinfarktforschung pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Clopidogrel (Iscover/Plavix)	Clopidogrel (Iscover/Plavix)	phase 3	P2Y12 receptor antagonist / Thienopyridine antiplatelet agent	P2Y12 receptor	Cardiovascular
Zodin (drug)	Zodin (drug)	phase 3

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Azienda Policlinico Umberto I · 1 shared drug class
Hospital Central San Luis Potosi, Mexico · 1 shared drug class
Sanofi · 1 shared drug class
Seung-Jung Park · 1 shared drug class
US Department of Veterans Affairs · 1 shared drug class
University of Pecs · 1 shared drug class
VA Office of Research and Development · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Stiftung Institut fuer Herzinfarktforschung:

Cite this brief

Drug Landscape (2026). Stiftung Institut fuer Herzinfarktforschung — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/stiftung-institut-fuer-herzinfarktforschung. Accessed 2026-05-17.